Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10494621 Crispr enzyme mutations reducing off-target effects

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
October 11, 2018
Date of Patent
December 3, 2019
Patent Application Number
16158295
Patent Citations Received
‌
US Patent 11597949 Optimized CRISPR-Cas double nickase systems, methods and compositions for sequence manipulation
‌
US Patent 11866726 Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
0
‌
US Patent 11624078 Protected guide RNAS (pgRNAS)
0
‌
US Patent 12123032 CRISPR enzyme mutations reducing off-target effects
0
‌
US Patent 12018275 Delivery and use of the CRISPR-CAS systems, vectors and compositions for hepatic targeting and therapy
0
‌
US Patent 11591581 Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disorders
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10494621
Patent Primary Examiner
‌
Nancy J Leith

Find more entities like US Patent 10494621 Crispr enzyme mutations reducing off-target effects

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.